New organoselenium compounds active against pathogenic bacteria, fungi and viruses

Chemical and Pharmaceutical Bulletin

Volumn 56, Issue 10, 2008, Pages 1423-1427

  Piȩtka Ottlik, Magdalena ^a   Wójtowicz Młochowska, Halina ^a   Kołodziejczyk, Katarzyna ^a   Piasecki, Egbert ^b   Młochowski, Jacek ^a  

^a WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Antimicrobial agent; Antiviral agent; Benzisoselenazol 3(2H) one; Ebselen; Organoselenium compound

Indexed keywords

2 (1 ADAMANTYL)BENZISOSELENAZOL 3(2H) ONE; 2 (1,3 DIHYDROXYISOPROPYL)BENZISOSELENAZOL 3(2H) ONE; 2 (2,2 DIETHOXYETHYL)BENZISOSELENAZOL 3(2H) ONE; 2 (2,2 DIMETHOXY 1 METHYLETHYL)BENZISOSELENAZOL 3(2H) ONE; 2 (3 CHLOROPHENYLCARBAMOYL)BENZISOSELENAZOL 3(2H) ONE; 2 [2 (N,N DIMETHYLAMINO)ETHYL]BENZISOSELENAZOL 3(2H) ONE METHYL IODIDE; 2 CARBOXYBENZISOSELENAZOL 3(2H) ONE ETHYL ESTER; 2 CARBOXYMETHYLBENZISOSELENAZOL 3(2H) ONE METHYL ESTER; 2 CYCLOHEXYLCARBAMOYLBENZISOSELENAZOL 3(2H) ONE; 2 HYDROXYMETHYLBENZISOSELENAZOL 3(2H) ONE; 2 PHENYLCARBAMOYLBENZISOSELENAZOL 3(2H) ONE; 2 PROPYLBENZISOSELENAZOL 3(2H) ONE; 2 PROPYLCARBAMOYLBENZISOSELENAZOL 3(2H) ONE; BENZISOSELENAZOL 3(2H) ONE DERIVATIVE; EBSELEN; ORGANOSELENIUM DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BACTERIAL STRAIN; CANDIDA ALBICANS; CYTOPATHOGENIC EFFECT; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; ENCEPHALOMYOCARDITIS VIRUS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS SIMULANS; VESICULAR STOMATITIS VIRUS;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTIFUNGAL AGENTS; ANTIVIRAL AGENTS; AZOLES; BACTERIA; BICYCLO COMPOUNDS, HETEROCYCLIC; CELL SURVIVAL; FUNGI; HUMANS; INDICATORS AND REAGENTS; MICROBIAL SENSITIVITY TESTS; ORGANOSELENIUM COMPOUNDS; VIRUSES;

EID: 54349124541     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.56.1423     Document Type: Article

References (15)

1. Mugesh G., du Mont W.-W., Sies H., Chem. Rev., 101, 2125-2179 (2001).
2. Soriano-Garcia M., Curr. Med. Chem., 11, 1657-1669 (2004).
3. Młochowski J., Kloc K., Lisiak R., Potaczek P., Wójtowicz H., Arkivoc, vi, 14-46(2007).
4. Mugesh G., Singh H. B., Chem. Soc. Rev., 29, 347-357 (2000).
5. Schewe T., Gen. Pharmacol., 26, 1153-1169 (1995).
6. Sies H., Free Radic. Biol. Med., 14, 313-323 (1993).
7. Młochowski J., Kloc K., Syper L., Inglot A. D., Piasecki E., Liebigs Ann. Chem., 1993, 1239-1244 (1993).
8. Inglot A. D., Młochowski J., Zielinska-Jenczylik J., Piasecki E., Ledwon T. K., Kloc K., Arch. Immun. Ther. Exp., 44, 67-75 (1996).
9. Wójtowicz H., Kloc K., Maliszewska I., Młochowski J., Piȩtka M., Piasecki E., Farmaco, 59, 863-868 (2004).
10. Lisiak R., Młochowski J., Palus J., Pol. J. Chem., 81, 1403-1411 (2007).
11. Palus J., Młochowski J., Juchniewicz L., Pol. J. Chem., 72, 1931-1936 (1998).
12. Lesser R., Weiss R., Chem. Ber., 57, 1077-1082 (1924).
13. Fong M. C., Schiesser C. H., J. Org. Chem., 62, 3103-3108 (1997).
14. Weber R., Renson M., Bull. Soc. Chim. Fr., 7, 1124-1126 (1976).
15. Osajda M., Młochowski J., Tetrahedron, 58, 7531-7537 (2002).